TCRR - Tcr2 Therapeutics Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - TCRR (1750019)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
6 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-05-25
TCRRTang Kevin C10%P - Purchase$1.72+50,0004,394,800+1%+$86,000
D
2023-05-22
TCRRMpm Asset Management LLC10%S - Sale+OE$1.88-70,1703,674,978-2%-$131,920
D
2023-05-22
TCRRGadicke AnsbertDir, 10%S - Sale+OE$1.88-70,1707,529,946-1%-$131,920
M
2023-05-11
TCRRTang Kevin C10%P - Purchase$1.95+44,9484,344,800+1%+$87,649
M
2023-05-08
TCRRTang Kevin C10%P - Purchase$1.95+83,9884,299,852+2%+$163,777
M
2023-05-03
TCRRTang Kevin C10%P - Purchase$1.89+289,5774,215,864+7%+$547,944

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top